Valerie Rodriguez-garcia

Array ( [id] => 7712323 [patent_doc_number] => 20120004408 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-01-05 [patent_title] => 'Use of Rosuvastatin Lactols as Medicaments' [patent_app_type] => utility [patent_app_number] => 13/255705 [patent_app_country] => US [patent_app_date] => 2010-03-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 5191 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13255705 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7670348 [patent_doc_number] => 20110319617 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-29 [patent_title] => 'Rosuvastatin and Atorvastatin Derivatives' [patent_app_type] => utility [patent_app_number] => 13/255700 [patent_app_country] => US [patent_app_date] => 2010-03-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 5676 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13255700 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7683487 [patent_doc_number] => 20100240924 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-23 [patent_title] => '2-ETHYL-4,6-DIMETHYL-PHENYL-SUBSTITUTED TETRAMIC ACID DERIVATIVES AS PEST CONTROL AGENTS AND/OR HERBICIDES' [patent_app_type] => utility [patent_app_number] => 12/721193 [patent_app_country] => US [patent_app_date] => 2010-03-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27350 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0240/20100240924.pdf [firstpage_image] =>[orig_patent_app_number] => 12721193 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7733953 [patent_doc_number] => 20120016142 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-01-19 [patent_title] => 'METHOD FOR PRODUCING HEXAFLUOROPROPYLENE OXIDE' [patent_app_type] => utility [patent_app_number] => 13/257176 [patent_app_country] => US [patent_app_date] => 2010-03-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 5608 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0016/20120016142.pdf [firstpage_image] =>[orig_patent_app_number] => 13257176 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6295960 [patent_doc_number] => 20100160334 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-24 [patent_title] => 'TRICYCLIC ANILIDE SPIROLACTAM CGRP RECEPTOR ANTAGONISTS' [patent_app_type] => utility [patent_app_number] => 12/718386 [patent_app_country] => US [patent_app_date] => 2010-03-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 33284 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0160/20100160334.pdf [firstpage_image] =>[orig_patent_app_number] => 12718386 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10506073 [patent_doc_number] => 09233936 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-01-12 [patent_title] => 'Process for the preparation of bosentan' [patent_app_type] => utility [patent_app_number] => 13/254548 [patent_app_country] => US [patent_app_date] => 2010-03-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2651 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13254548 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9762427 [patent_doc_number] => 08846752 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-09-30 [patent_title] => 'Isoflavone fatty acid ester derivatives, preparation method and pharmaceutical uses thereof' [patent_app_type] => utility [patent_app_number] => 13/582038 [patent_app_country] => US [patent_app_date] => 2010-03-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 4 [patent_no_of_words] => 7186 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13582038 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6501777 [patent_doc_number] => 20100215759 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-26 [patent_title] => 'PHARMACEUTICAL COMPOUNDS' [patent_app_type] => utility [patent_app_number] => 12/712906 [patent_app_country] => US [patent_app_date] => 2010-02-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 25274 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0215/20100215759.pdf [firstpage_image] =>[orig_patent_app_number] => 12712906 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7712325 [patent_doc_number] => 20120004409 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-01-05 [patent_title] => 'Purification of 1-[2-(2,4-dimethylphenylsulfanyl)phenyl]piperazine' [patent_app_type] => utility [patent_app_number] => 13/148088 [patent_app_country] => US [patent_app_date] => 2010-02-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 4890 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13148088 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6296234 [patent_doc_number] => 20100240617 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-23 [patent_title] => 'BICYCLIC SPHINGOSINE 1-PHOSPHATE ANALOGS' [patent_app_type] => utility [patent_app_number] => 12/705969 [patent_app_country] => US [patent_app_date] => 2010-02-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 20361 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0240/20100240617.pdf [firstpage_image] =>[orig_patent_app_number] => 12705969 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9749815 [patent_doc_number] => 08841290 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-09-23 [patent_title] => 'Substituted tetrahydronaphthalenes, method for the production thereof, and use thereof as drugs' [patent_app_type] => utility [patent_app_number] => 13/201400 [patent_app_country] => US [patent_app_date] => 2010-02-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 29589 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13201400 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6435116 [patent_doc_number] => 20100152457 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-17 [patent_title] => 'Intermediate compound for synthesis of viridiofungin a derivative' [patent_app_type] => utility [patent_app_number] => 12/656580 [patent_app_country] => US [patent_app_date] => 2010-02-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 30992 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0152/20100152457.pdf [firstpage_image] =>[orig_patent_app_number] => 12656580 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7491772 [patent_doc_number] => 08030496 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-10-04 [patent_title] => 'Intermediate compound for synthesis of viridiofungin a derivative' [patent_app_type] => utility [patent_app_number] => 12/656579 [patent_app_country] => US [patent_app_date] => 2010-02-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 30992 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/030/08030496.pdf [firstpage_image] =>[orig_patent_app_number] => 12656579 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6598908 [patent_doc_number] => 20100292231 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-18 [patent_title] => 'Indazole Compounds for Treating Inflammatory Disorders, Demyelinating Disorders and Cancers' [patent_app_type] => utility [patent_app_number] => 12/698597 [patent_app_country] => US [patent_app_date] => 2010-02-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 19502 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0292/20100292231.pdf [firstpage_image] =>[orig_patent_app_number] => 12698597 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6328230 [patent_doc_number] => 20100197754 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-05 [patent_title] => 'CRYSTALLINE N--5-chloro-4-(4-chloro-1-methyl-1H-pyrazol-5-yl)-2-thiophenecarboxamide hydrochloride' [patent_app_type] => utility [patent_app_number] => 12/695331 [patent_app_country] => US [patent_app_date] => 2010-01-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 8654 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0197/20100197754.pdf [firstpage_image] =>[orig_patent_app_number] => 12695331 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6592559 [patent_doc_number] => 20100130572 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-05-27 [patent_title] => 'CYTOSKELETAL ACTIVE COMPOUNDS, COMPOSITION AND USE' [patent_app_type] => utility [patent_app_number] => 12/695348 [patent_app_country] => US [patent_app_date] => 2010-01-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21478 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0130/20100130572.pdf [firstpage_image] =>[orig_patent_app_number] => 12695348 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6266955 [patent_doc_number] => 20100298315 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-25 [patent_title] => 'NOVEL 6-TRIAZOLOPYRIDAZINESULFANYL BENZOTHIAZOLE AND BENZIMIDAZOLE DERIVATIVES, METHOD FOR PRODUCTION THEREOF AND APPLICATION AS MEDICAMENTS AND PHARMNACEUTICAL COMPOSITIONS AND NOVEL USE AS MET INHIBITORS' [patent_app_type] => utility [patent_app_number] => 12/693736 [patent_app_country] => US [patent_app_date] => 2010-01-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 45140 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0298/20100298315.pdf [firstpage_image] =>[orig_patent_app_number] => 12693736 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6328026 [patent_doc_number] => 20100197725 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-05 [patent_title] => '1-OXO-ISOINDOLINE-4-CARBOXAMIDE AND 1-OXO-1,2,3,4-TETRAHYDROISOQUINOLINE-5-CARBOXAMIDE DERIVATIVES, PREPARATION AND THERAPEUTIC USE THEREOF' [patent_app_type] => utility [patent_app_number] => 12/693597 [patent_app_country] => US [patent_app_date] => 2010-01-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 39770 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0197/20100197725.pdf [firstpage_image] =>[orig_patent_app_number] => 12693597 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7811480 [patent_doc_number] => 08134011 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-03-13 [patent_title] => 'Oxazolidinium compounds and use as hydrate inhibitors' [patent_app_type] => utility [patent_app_number] => 12/693790 [patent_app_country] => US [patent_app_date] => 2010-01-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4229 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/134/08134011.pdf [firstpage_image] =>[orig_patent_app_number] => 12693790 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9239401 [patent_doc_number] => 08604193 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-12-10 [patent_title] => 'Processes for preparing HIV reverse transcriptase inhibitors' [patent_app_type] => utility [patent_app_number] => 13/146151 [patent_app_country] => US [patent_app_date] => 2010-01-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13415 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13146151 [rel_patent_id] =>[rel_patent_doc_number] =>)